Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
Medicine Availability
Support

Home > Safety Info > Safety Communication > Safety Alerts > Safety Alert of Risk of Sacroiliitis with Isotretinoin

Safety Alert of Risk of Sacroiliitis with Isotretinoin

Abdul Mateen Safety Alerts January 30, 2026January 30, 2026

60-Safety-Alert-of-Risk-of-Sacroiliitis-with-Isotretinoin Download

Share this:

Twitter
Facebook

← Guidance Document for Submission of Applications on Form-5F (CTD) for Registration of Pharmaceutical Drug Products for Human Use
Safety Alert of Risk of Idiopathic Intracranial Hypertension with Mesalazine →

Product Recalls
Safety Communication
Safety Reporting

Quick Navigation

Quick Navigation

Registered Drugs Index
Drug Pricing Index
List of Pharmaceutical Units

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem